Pfizer-BioNTech begin late-stage study of lead coronavirus vaccine candidate

Pfizer-BioNTech begin late-stage study of lead coronavirus vaccine candidate Pfizer-BioNTech begin late-stage study of lead coronavirus vaccine candidate India Today | Top Stories